However, current clinical trials of single, dual, and triple GLP-1 receptor agonists in adolescents provide insufficient data to adequately assess changes in lean mass trajectories or pubertal outcomes
Researchers at UC Irvine issue a warning that GLP-1RAs may be dangerous for children Source: UC Irvine School of Medicine Irvine, CA, August 28, 2023 A team of clinicians, exercise scientists, pharmaceutical scholars, ethicists and behavioral experts at the University of California, Irvine, outlined their concerns that the use of glucagon-like peptide-1 receptor agonists (GLP-1RAs) to treat childhood obesity and type 2 diabetes may have unintended and adverse consequences for childrens health
The number of studies currently included was limited, and additional studies were needed in the future
A perfect synergy blend with Vitamin C
Compared to the abstract of the original paper, the above is shorter and easier to understand yet simultaneously more informative
Support for Lung Function: glutathione supplementation benefit individuals with respiratory conditions by promoting lung health